AMP Annual Meeting & Expo 2025

AMP Annual Meeting & Expo 2025 The Association for Molecular Pathology (AMP) Annual Meeting & Expo 2025 is a premier scientific event dedicated to the latest advancements and innovations in molecular diagnostics and precision medicine. Taking place from November 11–15, 2025, this comprehensive conference brings together global professionals to explore emerging technologies, clinical applications, and industry trends shaping the future of cancer care, infectious diseases, and genomic testing.

2. Learning Objectives

• Explore innovative approaches to molecular diagnostics, including cell-free DNA testing and epigenetic signatures in lymphoma.

• Analyze the latest regulatory and legislative updates impacting Laboratory Developed Tests (LDTs) and bioinformatics pipelines.

• Evaluate the clinical implications of artificial intelligence and machine learning in molecular pathology and tumor profiling.

• Discuss emerging public health threats and advancements in infectious disease diagnostics, including avian influenza.

• Implement practical strategies for optimizing diagnostic stewardship, test utilization, and automation in the clinical laboratory.

3. Target Audience

Best for molecular pathologists, geneticists, and laboratory directors who want key updates on molecular diagnostics, tumor profiling, and AI.

4. Topics

1. Award for Excellence Recognition

2. Beyond the Genome Innovative Approaches to Molecular Diagnostics

3. Developing Robust Bioinformatic Pipelines and Regulatory Requirements

4. Emerging Public Health Threats Avian Influenza A(H5N1) and the Return of Vaccine-Preventable Diseases

5. LDTs Under the Microscope Regulatory and Legislative Updates

6. Transforming Cancer Care with Cell-Free DNA Testing

7. Hematopathology Plenary

8. Platform Presentations of Selected Informatics Abstracts

9. Platform Presentations of Selected Solid Tumor Abstracts

10. Platform Presentations of Selected Technical Topic Abstracts

11. Infectious Diseases Plenary

12. Case Studies in Genetics

13. Case Studies in Hematopathology

14. Case Studies in Infectious Diseases

15. Case Studies in Solid Tumors I

16. Case Studies in Solid Tumors II

17. Informatics Plenary

18. Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer

19. Advances in Oncogenic Evaluation and Nomenclature of Gene Fusions in Solid Tumors

20. Advancing Acute Leukemia Diagnosis The Role of Methylation Sequencing for Rapid Classification

21. Computational Assessment of Tumor Content

22. Optimizing Diagnostic Stewardship Clinician and Lab Director Perspectives on Effective Test Utilization

23. A Refresher in R Using R in Validations in the Clinical Pathology Lab

24. Epigenetic Signatures in Lymphoma Advancing Classification and Insights

25. From Targeted NGS Panels to Virtual Panels in the Era of Exome Sequencing

26. Implementing Pre-emptive Germline Genomic Testing for Preventive Medicine

27. Integrated Genomics Viewer Workshop

28. Genetics Plenary

29. Technical Topics Plenary

30. Applications of AI and Machine Learning for Clinical Implications

31. Automate to Innovate Practical Insights for Molecular Diagnostics Through Engineering Efficiency and Smart Automation

32. Optimizing Molecular Testing and Reporting for Myeloid Malignancies Bridging Oncologist Expectations with Laboratory Pr…

33. Self-Collection Navigating the Variables and Balancing the Pros and Cons

34. Platform Presentations of Selected Genetics Abstracts

35. Platform Presentations of Selected HemePath Abstracts

36. Platform Presentations of Selected Infectious Diseases Abstracts

37. Applications of Foundation Models in Molecular

38. Best Practices and Future Directions in Paired Tumor-Normal Molecular Profiling for Solid Tumors

39. Uncovering Clinically Significant Gene Fusions & Neoantigens Challenges and Innovations in Tumor Profiling

40. Women in Molecular Pathology Career Perspectives from Technologists and Pathologists

41. Technologist Session

42. Solid Tumors Plenary

43. Integrating Bioinformatics